• / Free eNewsletters & Magazine
  • / My Account

High Risk

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. UPDATE: Why there's nothing lurking under the bed for this market right now

    UPDATE: Why there's nothing lurking under the bed for this market right now

  2. Transgene Presents New Data with TG1050, an Immunotherapy Being Developed to Treat Chronic Hepatitis B, at The International Liver Congress™ 2015

    Transgene Presents New Data with TG1050, an Immunotherapy Being Developed to Treat Chronic Hepatitis B, at The International Liver Congress™ 2015

  3. ANGLE plc Updates Results on Ovarian Cancer Study

    ANGLE plc Updates Results on Ovarian Cancer Study

  4. CTI BioPharma and Baxter Announce Phase 3 Data of Pacritinib in Patients with Myelofibrosis to be Presented in Late-Breaking Session at ASCO

    CTI BioPharma and Baxter Announce Phase 3 Data of Pacritinib in Patients with Myelofibrosis to be Presented in Late-Breaking Session at ASCO

  5. Fitch: Raytheon's Increase of Commercial Cyber Sales Holds Risks

    Fitch: Raytheon's Increase of Commercial Cyber Sales Holds Risks

  6. Credit Suisse Profit Beats Forecasts -- 2nd Update

    Credit Suisse Profit Beats Forecasts -- 2nd Update

  7. Greek Bond Yields Hit Multiyear Highs

    Greek Bond Yields Hit Multiyear Highs

  8. Greek Bond Yields Hit Multiyear Highs on Rising Concerns Over Country's Economy

    Greek Bond Yields Hit Multiyear Highs on Rising Concerns Over Country's Economy

  9. IMBRUVICA® (ibrutinib) Longer-Term Follow-Up Data Demonstrate Durable Responses, Including Complete Responses, in Patients with Chronic Lymphocytic Leukemia (CLL)

    IMBRUVICA® (ibrutinib) Longer-Term Follow-Up Data Demonstrate Durable Responses, Including Complete Responses, in Patients with Chronic Lymphocytic Leukemia (CLL)

  10. European Stocks Recover From Fierce Selloff

    European Stocks Recover From Fierce Selloff

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.